Skip to main content
. 2018 Mar 1;15(5):6681–6687. doi: 10.3892/ol.2018.8145

Table III.

Multivariate analysis of factors associated with overall survival.

Variable HR 95% CI P-value
Non-cCR 2.27 0.87–5.94 0.0955
Primary stage IV 1.14 0.64–2.03 0.6495
Metastatic sites no. ≥3 1.79 0.95–3.36 0.0714
Visceral sites no. ≥2 1.07 0.62–1.86 0.7968
NLR≥1.90 1.75 1.09–2.85 0.0218

Bold type indicates a statistically significant difference (P<0.05). HR, hazard ratio; CI, confidence interval; cCR, clinical complete response; NLR, neutrophil-lymphocyte ratio.